Caplin Point Laboratories Limited
₹1,687.1-1.25%Apr 13, 3:45 PM IST
CAPLIPOINT•Health Technology•Pharmaceuticals: Major
Current Price
₹1,687.1-1.25%
Apr 13, 3:45 PM ISTMarket Cap₹12,988.12 Cr
Market Cap₹12,988.12 Cr
Business Overview
Caplin Point Laboratories Limited operates through 1 main business divisions including Pharmaceuticals.
Business Hierarchy Structure for Caplin Point Laboratories Limited
- Caplin Point Laboratories Limited
- Pharmaceuticals
- Emerging Markets
- Generics
- Branded Generics
- Specialty Products
- Product Portfolio
- Tablets
- Capsules
- Ophthalmic
- Softgel Capsules
- Ointments
- Creams & Gels
- Powder for injections
- Suppositories & Ovules
- Pre-Mix Bag Formulations
- Inhalers & Sprays
- IV infusion
- Oral Solid Dosages
- Injectables (Liquid & Lyophilized)
- Injectables (Prefilled Syringes)
- Ready-to-Use Bags
- Regulated Markets
- Niche Products
- Injectables
- Ready-To-Use Bags
- PP Vials
- Injectable Suspensions
- Ophthalmic Solutions
- Emulsions
- Oncology Drugs
- Biosimilars and Biologics (Planned)
- General API
- OSD & Injectable
- Oncology API
- Oral Solid Dosages
- Manufacturing & R&D
- Manufacturing Units
- CP I (Puducherry)
- CP X (Visakhapatnam)
- CP IV (Gummidipoondi)
- CP IX (Kakkalur)
- R&D Facilities
- CP III (Amaris Clinical CRO, Chengalpattu)
- CP VI (APIs, Intermediates, Key Starting Materials - Hyderabad)
- CP VII (TICEL Bio-Park - Bioequivalent dosage forms, Taramani, Chennai)
- CP VIII (APIs, Intermediates, Key Starting Materials - Perungudi, Chennai)
- Focus on difficult-to-manufacture products
- Manufacturing Units
- Distribution
- Own Distribution Network
- Stock and Sale Model
- Emerging Markets
- Pharmaceuticals